Article info

Download PDFPDF
Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

Authors

  • Amand F Schmidt Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands Division Heart and Lungs, Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Lucy S Pearce Department of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK PubMed articlesGoogle scholar articles
  • John T Wilkins Department of Medicine (Cardiology), Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA PubMed articlesGoogle scholar articles
  • Juan P Casas Farr Institute of Health Informatics, University College London, London, UK PubMed articlesGoogle scholar articles
  • Aroon D Hingorani Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Amand F Schmidt, Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London WC1E 6BT, UK; amand.schmidt{at}ucl.ac.uk
View Full Text

Citation

Schmidt AF, Pearce LS, Wilkins JT, et al
Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

Publication history

  • First published February 14, 2018.
Online issue publication 
June 12, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.